Intellectual Property India Publishes Patent Application for Improved Linkers And Methods For The Synthesis Of Anti-Transferrin Receptor Antibody Conjugates

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617092452 A) filed by Arrowhead Pharmaceuticals, Inc. on July 30, 2026, for Improved Linkers And Methods For The Synthesis Of Anti-Transferrin Receptor Antibody Conjugates.

Inventors include Fowler-Watters, Matthew; and Glebocka, Agnieszka.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The present disclosure relates to improved linkers for conjugating oligonucleotidebased agents (e.g., RNAi agents) to an antibody or antibody fragment (e.g., anti- transferrin receptor (TfR1) antibodies or fragments).

Disclaimer: Curated by HT Syndication....